Literature DB >> 3375460

Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.

A C Begg1, L Moonen, I Hofland, M Dessing, H Bartelink.   

Abstract

Cell kinetic parameters in human tumours were determined by in vivo labelling with iododeoxyuridine (IUdR) followed by flow cytometric analysis of tumour biopsies after staining with a monoclonal antibody against IUdR-DNA. The purpose of this study was to determine the variation in these kinetic parameters from area to area within the same tumour. Each patient received a single i.v. injection of IUdR and the biopsy or operation specimen was taken several hours later. Multiple biopsies were taken or the operation specimen was cut into several pieces. Tumour material was stored in ethanol. Each piece was subsequently processed and stained for analysis separately. The duration of DNA synthesis (Ts), the labelling index (L.I., percent IUdR-labelled cells) and the potential doubling time (Tpot) were determined for each sample. The mean and standard deviation (variation between pieces) for each parameter was calculated for each tumour. The coefficient of variation (C.V.) provided the measure of intratumoural variation. Thirteen tumours were investigated, 6 of which were transitional cell carcinomas of the bladder and 7 of which were squamous cell carcinomas, mostly of the head and neck. Ts values ranged from 4.1 to 17.2 h (mean 9.5 h), L.I. values from 1.6 to 18.6% (mean 9.7%) and Tpot values from 2.3 to 15.1 days (mean 7.2 days). Mean C.V.s for Ts, L.I. and Tpot were 10, 24 and 27%, respectively. Most of the variation in Tpot (calculated from the other two parameters), came from the L.I., with Ts showing much less intratumoural variations. It is concluded that this kinetic method using low IUdR doses can be successfully applied in human tumours and has sufficient accuracy for predictive assay applications in which tumours need to be classified according to their proliferation rates. Further developments are required to distinguish normal and malignant cells flow cytometrically, particularly for diploid tumours.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3375460     DOI: 10.1016/0167-8140(88)90205-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  16 in total

Review 1.  Update on special techniques in routine cytopathology.

Authors:  I D Buley
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

2.  A new intraperitoneal tumor model in the rat.

Authors:  J D Nagel; G Los; A C Begg; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.

Authors:  S B Ewers; R Attewell; B Baldetorp; A Borg; E Långström; D Killander
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

4.  Bax alpha perturbs T cell development and affects cell cycle entry of T cells.

Authors:  H J Brady; G Gil-Gómez; J Kirberg; A J Berns
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

5.  New, simple model of mesenteric lymph node metastases in the rat.

Authors:  J D Nagel; W J Mooi; J G McVie
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

6.  Growth patterns and cell kinetics of human osteosarcoma xenografts in serial passages in nude mice analyzed by in vivo labelling with iododeoxyuridine.

Authors:  L A Broström; S Crnalic; R Löfvenberg; L Boquist; R Stenling
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 7.  Continuous, hyperfractionated, accelerated radiotherapy (CHART).

Authors:  S Dische; M I Saunders
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

8.  Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.

Authors:  M S Wilson; C M West; G D Wilson; S A Roberts; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

9.  An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers.

Authors:  M S Wilson; C M West; G D Wilson; S A Roberts; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

10.  Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.

Authors:  S Schultz-Hector; A C Begg; I Hofland; J Kummermehr; M Sund
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.